How should I manage a 75‑year‑old male two weeks after left total knee arthroplasty who presents with orthostatic hypotension, anemia, leukocytosis, thrombocytosis, hypoalbuminemia, significant insomnia with restless‑leg syndrome, and is currently taking apixaban (Eliquis), losartan, hydrochlorothiazide (held), iron supplement, acetaminophen, rosuvastatin, magnesium glycinate, and tizanidine?

Management of Post-TKA Patient with Orthostatic Hypotension and Anemia

Continue oral iron supplementation aggressively, hold HCTZ permanently, titrate losartan based on home BP readings, ensure adequate hydration, and monitor hemoglobin in 1-2 weeks—transfusion is not indicated at Hgb 8.9 g/dL in this asymptomatic patient without cardiovascular disease.

Immediate Blood Pressure Management

You correctly held the HCTZ. The orthostatic hypotension (BP 104/59 with symptomatic dizziness on standing) is multifactorial—likely from postoperative anemia (Hgb 8.9), surgical blood loss, inadequate fluid intake, and excessive antihypertensive therapy. 1

Antihypertensive Adjustment

• Discontinue HCTZ permanently in this post-surgical setting
• Hold losartan temporarily if home BP readings remain <110/60 or if orthostatic symptoms persist
• Resume losartan at reduced dose (e.g., 50% of current dose) only when BP consistently >120/70 and asymptomatic
• Instruct patient to check BP twice daily (sitting and standing) and report values

Hydration Strategy

• Encourage oral fluid intake of 2-3 liters daily unless contraindicated
• Consider oral rehydration solutions if plain water intake is inadequate
• Avoid rapid position changes; sit at bedside 1-2 minutes before standing

Common pitfall: Reflexively treating all postoperative hypotension with IV fluids. A passive leg raise test would help differentiate preload-dependent from preload-independent hypotension 1, though in this outpatient setting, empiric oral hydration and medication adjustment are more practical.

Anemia Management

The Hgb of 8.9 g/dL represents expected postoperative anemia and does NOT require transfusion in this asymptomatic patient without cardiovascular disease. 2

Iron Supplementation

• Continue daily oral iron supplementation (which he appropriately resumed postoperatively)
• Consider increasing to twice-daily dosing if tolerated
• Recheck CBC in 1-2 weeks to confirm upward trend
• Target Hgb >10 g/dL over the next 2-4 weeks

Transfusion Threshold

The evidence is clear: In patients without cardiovascular disease, Hgb 6-9 g/dL carries minimal mortality risk (OR 1.4), while patients WITH cardiovascular disease at the same Hgb have dramatically increased mortality (OR 12.3). 2 This patient has no documented CVD, is asymptomatic at rest, and manages pain with Tylenol alone—transfusion would be inappropriate and potentially harmful.

Key consideration: His low total protein (6.0) and albumin (3.9) suggest mild postoperative catabolism/inflammation, which is expected. This is NOT anemia of chronic disease requiring ESA therapy 2, but rather acute surgical blood loss with iron deficiency anemia.

Hematologic Abnormalities

Leukocytosis (WBC 11.8) and Thrombocytosis (Platelets 497)

• These are expected reactive changes 2 weeks post-TKA
• Leukocytosis: Likely surgical stress response; no fever or wound concerns reported
• Thrombocytosis: Normal reactive thrombocytosis post-surgery; platelets <600,000 rarely cause complications 3
• No intervention needed—recheck CBC in 1-2 weeks; should normalize by 4-6 weeks post-op

Low MCV/MCH/MCHC Pattern

• Suggests iron deficiency anemia (consistent with history)
• Normal MCV (90.5) with low MCHC (30.0) indicates early iron deficiency
• Ferritin and iron studies would be helpful if not improving in 2 weeks, though not urgent 2

Anticoagulation Management

Continue Eliquis (apixaban) 2.5 mg twice daily as prescribed for VTE prophylaxis post-TKA. 4

• Standard duration for knee arthroplasty is 12 days per FDA labeling 4
• He is currently day 14 post-op—confirm with orthopedic surgeon whether to continue or stop
• If bleeding risk is elevated (Hgb 8.9), consider stopping now that he's past the highest VTE risk period
• Do NOT hold due to anemia alone—the major bleeding rate with apixaban 2.5 mg BID post-TKA is <1% 4, 5

Sleep Disturbance Management

The severe insomnia (2 hours nightly) is likely multifactorial: postoperative pain, restless leg syndrome, anxiety, and possibly tizanidine timing.

Immediate Interventions

• Optimize tizanidine timing: Currently takes 4 mg at night; may need earlier dosing (e.g., 6-8 PM) to avoid middle-of-night muscle cramps
• Address RLS: Coordinate with neurology; magnesium glycinate is appropriate but may need dose adjustment or additional RLS-specific therapy
• Sleep hygiene: Avoid Fitbit sleep tracking (creates anxiety), establish consistent bedtime routine, limit daytime napping despite fatigue

Pharmacologic Considerations

• Consider short-term low-dose trazodone (25-50 mg) or melatonin (3-5 mg) at bedtime
• Avoid benzodiazepines (fall risk with orthostatic hypotension)
• Caution with sedatives given orthostatic hypotension risk

Physical Therapy Clearance

He is appropriately cleared for PT starting soon. 6

• Ensure PT staff is aware of orthostatic hypotension—gradual position changes, BP monitoring during first session
• Weight-bearing as tolerated is standard 6
• His comparison to better recovery than prior TKA is reassuring

Follow-Up Plan

1 Week

• Phone check-in: BP readings, orthostatic symptoms, sleep quality
• Adjust losartan based on BP trends

2 Weeks (In-Person)

• Repeat CBC: Expect Hgb 9.5-10.5 g/dL if iron supplementation effective
• Recheck BP sitting/standing
• Assess wound healing, PT progress
• If Hgb not improving: Check ferritin, TIBC, transferrin saturation 2

6 Weeks

• Repeat CBC: Expect Hgb >11 g/dL
• Reassess need for continued iron supplementation
• Confirm WBC and platelets normalized

Critical safety point: Educate patient on fall precautions given orthostatic hypotension. Use assistive device if needed, avoid hot showers (vasodilation), and rise slowly from sitting/lying positions.